Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents on prescription pharmaceuticals. The company focuses on drug discovery leads that are high in certainty and globally competitive. The company was started in 1717 in Dosho-machi, Osaka. Throughout its 300-year history, ONO has dedicated itself to developing innovative and breakthrough pharmaceutical products.

Centre Hospitalier Régional Universitaire De Besançon is a private company headquartered in France that operates hospital.

Nanjing Legend Biotechnology Co., Ltd. is a private company headquartered in Nanjing, China, that develops tumor cell immunotherapies.

Cellid is a research and development bioventure company. The company is developing immunotherapeutic vaccines, CeliVax. The CeliVax is a personalized vaccine which uses patient's own cells.

Humanitas Mirasole SpA provides healthcare services. It offers oncology, cardiology, diagnostic, orthopaedic, dental, chest, vascular, plastic surgery, asthma care, and gynaecology treatments. The company is headquartered in Rozzano, Italy.

Akzo Nobel NV is a holding company, which engages in the manufacture and sale of coating and paint products. engages in the production and marketing of paints and coatings. It operates through the following segments: Decorative Paintings, Performance Paintings, and Corporate and Others. The Decorative Paints segment manufactures and supplies a range of interior and exterior decoration and protection products for professional and do-it-yourself markets. The Performance Coatings segment produces automotive and aerospace; industrial; marine and protective; and powder coatings. The company was founded in 1792 and is headquartered in Amsterdam, Netherlands.

The Group has strengthened its presence in Italy and has grown to become an international pharmaceutical company. The research for the development of original and innovative products, to improve the health and quality of life of people, is an integral and fundamental part of the activities of the company that has fully developed four products and, over the years, has obtained over 700 patents for more than 40 countries . The Group enjoys an image of seriousness and dynamism and believes in promoting the culture of Corporate Social Responsibility in order to provide a service to the community.

Weihai Life Group engages in pharmaceutical production. It has passed the GMP certification of the national pharmaceutical production standards. The company has modern production equipment, strict management systems, and advanced management methods.

Qingdao Marine Biomedical Research Institute Co., Ltd., established on 2013-07-26, Business scope includes licensed projects:Drug Wholesale;pharmaceutical production;Drug retail;Pharmaceutical commissioned production;Health food production;Health food sales;food production;food business(Selling prepackaged food);food business(sell bulk food);food business;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Sales of formula food for special medical purposes;Production of formula food for special medical purpose;Cosmetic production;Production of sterile equipment;Disinfection equipment sales;Inspection and testing service;Disinfectant production(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;New material technology research and development;New material technology promotion service;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of daily chemical products;Sales of daily chemical products;Cosmetics Wholesale;Cosmetics Retail;Disinfectant sales(Free of Hazardous Chemicals);Extraction of marine bioactive substances,purification,Synthesis technology research and development;Research and development of bio-based materials technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Offshore engineering design and module design and manufacturing services;Asset management services for self-owned capital investment.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Apceth GmbH & Co. KG develops cell therapy products. It focuses on the isolation and use of adult stem cells from donors and patients for a therapy optimization in the field of therapeutic and regenerative cell therapy. The firm offers research and non clinical development services, pharmaceutical technical equipment and technology, and hold interest in translational science. The company was founded by Ralf Huss in November 2007 and is headquartered in Munich, Germany.

Fuzhou Tuoxin Tiancheng Biotechnology Co., Ltd., established on 2017-04-17, The scope of business includes engaging in biological,In the field of medicine(genetically modified organism,Except human stem cell genetic diagnosis)technology development,technology transfer,technical consulting,Technical Services;In vitro diagnostic reagents,biopharmaceutical products,R&D of medical devices,Production,Sales;laboratory instrument,Reagent,Sales of consumables;Self-operated and agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Funakang Biotechnology Co., Ltd., established on 2015-02-03, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology Import and Export;Metal Material Sales;Metal Products Sales;Retailing of computer software, hardware and auxiliary equipment;internet sales(Except for products that require a license for sale);Daily necessities sales;Machinery sales;Sales of building materials;Hardware retail;Food Additive Sales;Cosmetics Retail;Cosmetics Wholesale;food sales(Only sell prepackaged food).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Nanjing Congyi Pharmaceutical Technology Co., Ltd., established on 2006-07-04, Business scope includes medical technology development and transfer,Medical Technology Services,Medical Consulting Services;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export);clinical research(Does not include diagnosis and treatment);Development and transfer of new medical technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

ICCAS was founded in 1956. ICCAS is a multi-disciplinary research institute dedicated to the basic research in broad fields of chemical sciences, and to the key developments of the innovative high technologies aiming to the imperative national needs and important strategic targets, as well as to the collaborative high-technology applications and transfers. ICCAS is one of China’s leading chemistry research institutions with high international reputation.